NEM:XETRNemetschek SE Analysis

Newmont’s shares are trading at $90.83, well below the 20‑day ($96.17), 50‑day ($103.46) and 200‑day ($103.89) simple moving averages, signaling a bearish price trend. The RSI sits at 38, indicating the stock is approaching oversold territory, while the MACD histogram has turned positive, offering a bullish signal despite the overall negative MACD line. Volatility is elevated at nearly 50% over the past 30 days and the computed beta of 1.53 points to heightened market sensitivity, which is reflected in the recent 8.7% one‑month price decline driven by a pullback in gold prices amid inflation worries. Recent leadership appointments—including a new CFO, COO and CTO—add a layer of operational optimism, and the upcoming Q2 earnings call will be a key catalyst for direction. Fundamentally, the company delivers robust revenue growth of 45.8% and exceptional margins (gross 67.4%, operating 61.4%). The forward EPS of $10.76 and a forward P/E of 8.44 underscore earnings acceleration, while the DCF‑derived fair value of $330.73 suggests the stock is severely undervalued with an upside potential of roughly 47% over the current price. Cash generation is strong, with free cash flow near $9.8 bn and a modest dividend payout ratio of 13%, supporting dividend sustainability. Analyst consensus remains a “Buy” with a median target near $132, reinforcing the long‑term attractiveness despite short‑term technical weakness.